• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1011709-38
Device Problems Difficult to Remove (1528); Material Separation (1562); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/12/2023
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a lesion in the anterior tibial artery.A 3.0x38mm xience prime drug eluting stent (des) was advancing on an unspecified.014 guide wire (gw) when the des became stuck with the guide wire outside of the anatomy and could not be advanced into the sheath.The des could not be removed from the guide wire as the two devices were stuck together, so the surgeon cut and removed the guide wire and exchanged it with a new one.When the surgeon cut the guide wire, the shaft of the des separated.A new 3.0x38mm xience prime des and guide wire were used to successfully complete the procedure.There were no reported adverse patient effects and no clinically significant delays in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was confirmed.The reported difficulty to advance and difficulty to remove could not be confirmed due to the condition the device was received for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulties; however, factors that may contribute to the difficult advancing and removing the stent delivery system (sds) from the guide wire causing resistance between the devices may include, but are not limited to, manufacturing damage, device placement technique, buildup of procedural contaminants in the guide wire lumen, inner diameter of guide wire lumen, condition of the guide wire, or damage to the distal shaft of the catheter.Additionally, factors that may contribute to a material separation (shaft) include, but are not limited to, excessive force applied to device during use, interaction with accessory devices, and/or interaction with the patient¿s anatomy.It should be noted the account indicated the guidewire was cut to remove the system at which time any damage to the stent delivery system would have occurred.It is unclear if the separation occurred when the guidewire was cut or if it separated due to case circumstances, the account was not able to be more specific when additional information was requested.Based on the information provided it is unknown what may have caused the reported material separation (shaft).Based on the information provided and without the return of the complete delivery system a conclusive cause for the reported difficulties cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17309307
MDR Text Key318985009
Report Number2024168-2023-07424
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011709-38
Device Lot Number2040641
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/07/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/19/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age66 YR
Patient SexMale
Patient Weight38 KG
-
-